Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine, commonly abbreviated AEDG. It belongs to the family of short peptides developed by Russian gerontologist Vladimir Khavinson, often referred to as Khavinson peptides or peptide bioregulators.
Select Variant
Selected price
$75.00
Add $150.00 for free Canadian shipping.
What Cartalax Is Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly, or "AEDG"). It was developed by Vladimir Khavinson, a Russian gerontologist and researcher who has created an entire family of short synthetic peptides — often called "Khavinson peptides" or peptide bioregulators — each theoretically targeted at a specific organ or tissue system. Cartalax is the one specifically designed and marketed for cartilage tissue. It's part of a broader product family that includes peptides like: Vladonix (immune system) Chonluten (bronchial/lung tissue) Svetinorm (liver) Pinealon (brain/pineal gland) Testoluten (testes/reproductive) Cartalax (cartilage) Each is marketed around Khavinson's theory that short peptides can act as tissue-specific "bioregulators." Proposed Mechanism of Action (Khavinson's Theory) The overarching concept behind Cartalax and the other Khavinson peptides is called "peptide bioregulation theory." According to this framework: Short peptides (2-4 amino acids) are proposed to penetrate the cell nucleus and bind to DNA They're theorized to help regulate gene expression and protein synthesis in a tissue-specific manner For Cartalax specifically, the claim is that it helps regulate genes involved in chondrocyte (cartilage cell) function, potentially supporting cartilage matrix production and slowing degenerative processes The broader theoretical framework suggests these peptides can help "restore" age-related declines in tissue-specific protein synthesis, tied into Khavinson's larger interest in aging and longevity science What Cartalax Is Cartalax is a synthetic tetrapeptide with the sequence Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly, or "AEDG"). It was developed by Vladimir Khavinson, a Russian gerontologist and researcher who has created an entire family of short synthetic peptides — often called "Khavinson peptides" or peptide bioregulators — each theoretically targeted at a specific organ or tissue system. Cartalax is the one specifically designed and marketed for cartilage tissue. It's part of a broader product family that includes peptides like: Vladonix (immune system) Chonluten (bronchial/lung tissue) Svetinorm (liver) Pinealon (brain/pineal gland) Testoluten (testes/reproductive) Cartalax (cartilage) Each is marketed around Khavinson's theory that short peptides can act as tissue-specific "bioregulators." Proposed Mechanism of Action (Khavinson's Theory) The overarching concept behind Cartalax and the other Khavinson peptides is called "peptide bioregulation theory." According to this framework: Short peptides (2-4 amino acids) are proposed to penetrate the cell nucleus and bind to DNA They're theorized to help regulate gene expression and protein synthesis in a tissue-specific manner For Cartalax specifically, the claim is that it helps regulate genes involved in chondrocyte (cartilage cell) function, potentially supporting cartilage matrix production and slowing degenerative processes The broader theoretical framework suggests these peptides can help "restore" age-related declines in tissue-specific protein synthesis, tied into Khavinson's larger interest in aging and longevity science
No reviews yet. Be the first.
No reviews yet — yours could be first.
Yes. Product pages, cart, and checkout use the current catalog data for active variants, availability, prices, and totals.
Canadian orders ship free when the merchandise subtotal is at least $150 CAD. Orders below that threshold use a flat $25.00 CAD shipping charge.
Checkout creates a pending order. The order is confirmed only after the e-transfer is reviewed and marked paid by an admin.
Contact Nuforme as soon as possible. Orders should be reviewed carefully before checkout because fulfillment starts after payment is confirmed.
BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. Its sequence is based on a partial segment of a protective protein found in human gastric juice, and the synthetic form was developed for greater stability than the naturally occurring compound.
CJC-1295 + Ipamorelin is a peptide combination studied in research focused on growth hormone pathways and the interaction between GHRH and ghrelin receptor signaling.
Epithalon — also written Epitalon or Epithalone — is a synthetic tetrapeptide composed of four amino acids: alanine, glutamic acid, aspartic acid and glycine (AEDG). It was developed from naturally occurring peptide components associated with the pineal gland.
Editorial guidance only — current pricing and stock live on each product page.
A practical buyer’s guide to peptide COAs, HPLC purity, mass spectrometry, batch identity, and the supplier transparency signals that matter before purchasing research peptides in Canada.
Read articleCartalax
$75.00
